Hepatitis B reactivation following immunosuppressive therapy and screening adherence: A neglected problem?;Hepatitis-B-Reaktivierung unter Chemotherapie und Screening-Adhärenz: ein unterschätztes Problem?

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 28-29, 2012, Pages 1458-1462

  Borde, J P ^a,b   Kern, W V ^a   Becker, J ^c   Bertz, H ^a   Hubner J ^a   Offensperger, W B ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Klinik fur Gastroenterologie Hepatologie und Infektiologie   (Germany)

^c Ortenauklinikum Offenburg Gengenbach ^*  (Germany)

Author keywords

chemotherapy; hepatitis B; reactivation; screening

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ALLOGENEIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOEMBOLIZATION; DATA ANALYSIS; HEPATITIS B; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; SCREENING; SEROLOGY;

ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHECKLIST; CHEMOEMBOLIZATION, THERAPEUTIC; EMIGRANTS AND IMMIGRANTS; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MASS SCREENING; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; VIRUS ACTIVATION;

EID: 84863195718     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1305102     Document Type: Review

References (18)

1. Andersen ES, Gerstoft J, Weis N. Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis. Int J Hematol: 2010; 92 378 380
2. Artz AS, Somerfield MR, Feld JJ et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol: 2010; 28 3199 3202
3. Centers for Disease Control and Prevention Viral hepatitis. http://www.cdc.gov/hepatitis, Zugriff 13.6.2012
4. Cornberg M, Protzer U, Petersen J et al. [Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol: 2011; 49 871 930
5. Day FL, Link E, Thursky K et al. Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists. J Oncol Pract: 2011; 7 141 147
6. Lee R, Vu K, Bell CM et al. Screening for hepatitis B surface antigen before chemotherapy: current practice and opportunities for improvement. Curr Oncol: 2010; 17 32 38
7. Liang R. How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood: 2009; 113 3147 3153
8. Lock G, Helmich F, Bertram M. Drohendes Leberversagen nach Chemoimmuntherapie-induzierter Reaktivierung einer Hepatitis B - erfolgreiche Therapie mit Entecavir. Dtsch med Wochenschr 2012; 137 1248 1250
9. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology: 2009; 50 661 662
10. Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol: 2011; 17 1531 1537
11. Robert Koch Institut Zur Situation bei wichtigen Infektionskrankheiten in Deutschland. Virushepatitis B, C und D im Jahr 2010. Epidemiol Bull 29/2011
12. von Wagner M, Zeuzem S. Prophylaxe und Therapie der Reaktivierung einer Hepatitis B bei Immunsuppression. Dtsch Med Wochenschr: 2009; 134 255 258
13. Wands JR, Chura CM, Roll FJ et al. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology: 1975; 68 105 112
14. Weinbaum CM, Williams I, Mast EE et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep: 2008; 57 08 1 20
15. Yeo W, Chan PK, Hui P et al. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study. J Med Virol: 2003; 70 04 553 61 (Pubitemid 36734719)
16. Yeo W, Chan PK, Zhong S et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol: 2000; 62 03 299 307
17. Sarrazin C, Berg T, Ross RS et al. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol: 2010; 48 289 351
18. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol: 2012; 9 156 166